Provided by Tiger Fintech (Singapore) Pte. Ltd.

Praxis Precision Medicines, Inc.

189.99
+27.2816.77%
Post-market: 188.00-1.9900-1.05%19:59 EDT
Volume:4.43M
Turnover:833.77M
Market Cap:4.00B
PE:-15.41
High:203.58
Open:178.90
Low:178.14
Close:162.71
52wk High:205.89
52wk Low:26.70
Shares:21.05M
Float Shares:16.04M
Volume Ratio:1.51
T/O Rate:27.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.3300
EPS(LYR):-10.2095
ROE:-60.98%
ROA:-37.98%
PB:9.89
PE(LYR):-18.61

Loading ...

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

GlobeNewswire
·
Oct 17

Buy Rating for Praxis Precision Medicines Driven by Ulixacaltamide’s Promising Phase III Results and Market Potential

TIPRANKS
·
Oct 17

Promising Potential of Praxis Precision Medicines: Buy Rating on Ulixacaltamide’s Strong Phase 3 Results and Market Opportunity

TIPRANKS
·
Oct 17

Top Midday Gainers

MT Newswires Live
·
Oct 17

Praxis Precision's tremor-drug trial has succeeded where others have failed. The stock is skyrocketing.

Dow Jones
·
Oct 17

Praxis Precision price target raised to $232 from $115 at H.C. Wainwright

TIPRANKS
·
Oct 17

Praxis Precision Med Is Maintained at Buy by Needham

Dow Jones
·
Oct 17

Praxis Precision price target raised to $275 from $76 at Baird

TIPRANKS
·
Oct 17

A Treatment for Tremors Is Back From the Dead. This Stock Is Up 200%. -- Barrons.com

Dow Jones
·
Oct 17

BUZZ-U.S. STOCKS ON THE MOVE-DoorDash, Praxis, Snowflake

Reuters
·
Oct 16

LifeSci Capital Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)

TIPRANKS
·
Oct 16

Buy Rating Affirmed for Praxis Precision Medicines Following Positive Phase 3 Study Results

TIPRANKS
·
Oct 16

Praxis Precision Medicines Inc : Needham Raises Target Price to $250 From $80

THOMSON REUTERS
·
Oct 16

Praxis Precision price target raised to $300 from $65 at Jefferies

TIPRANKS
·
Oct 16

Praxis Precision price target raised to $350 from $155 at Guggenheim

TIPRANKS
·
Oct 16

US Stock Movement | Praxis Precision Medicines (PRAX.US) Soars 240% on Positive Progress in Essential Tremor Drug Research

Stock News
·
Oct 16

Stock Track | Praxis Precision Medicines Soars 208% on Positive Phase 3 Results for Essential Tremor Drug

Stock Track
·
Oct 16

Praxis Precision Medicines Shares Nearly Triple After Movement Disorder Drug Meets Main Goals of Two Trials, Last up 180%

THOMSON REUTERS
·
Oct 16

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines, Fossil Group, T-Mobile

Reuters
·
Oct 16

Praxis Precision Medicines Exec Says Co Has Completed 80% of All Documents Related to Nda Submission - Conf Call

THOMSON REUTERS
·
Oct 16